Recombinant CD44v9 Antibody
CD44 participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. The additional 10 exons (v1 to v10) are only expressed by alternative splicing of the nuclear RNA. The expression of specific cell adhesion molecule CD44 splice variants has been reported to be associated with metastasis in certain human malignancies.
Product Specifications
Specifications
Immunohistochemistry (FFPE) : 1-2 µg/mL for 30 min at RT
UniProt
P16070
Host
Mouse
Reactivity
Human
Immunogen
An amino acid sequence from the variant 9 domain of CD44 was used as the immunogen for the recombinant CD44v9 antibody.
Clonality
Recombinant Monoclonal
Isotype
IgG1 k
Clone
RCD44v9/1459
Type
Recombinant
Applications
IHC-P
Purity
Protein G affinity chromatography
Format
Purified
Buffer
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
Reconstitution
Store the recombinant CD44v9 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Limitations
This recombinant CD44v9 antibody is available for research use only.
Storage Conditions
Store the recombinant CD44v9 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide) .
Product Datasheet
https://www.nsjbio.com/tds-pdf/recombinant-cd44v9-antibody-rcd44v91459-v3573
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05% sodium azide
CAS Number
9000-83-3
Location
Cell surface, cytoplasmic
Image Legend
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
(S) -2-Amino-2- (4-fluoro-3-methoxyphenyl) acetic acid hydrochloride
(S) -2-Amino-2- (4-fluoro-3-methoxyphenyl) acetic acid hydrochloride
TAFV GP1 Protein (C-His, Tai Forest ebolavirus (strain Cote d'Ivoire-94) (TAFV) (Cote d'Ivoire Ebola virus) )
